Recap: Champions Oncology Q2 Earnings
$CSBR
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Champions Oncology (NASDAQ:CSBR) reported its Q2 earnings results on Tuesday, December 12, 2023 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Champions Oncology beat estimated earnings by 11.76%, reporting an EPS of $-0.15 versus an estimate of $-0.17.
Revenue was down $2.71 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.06 which was followed by a 1.45% drop in the share price the next day.
Here's a look at Champions Oncology's past performance:
| Quarter | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.12 | -0.03 | -0.01 |
| EPS Actual | -0.16 | -0.17 | -0.16 | 0.01 |
| Revenue Estimate | 13.06M | 12.86M | 13.13M | 13.79M |
| Revenue Actual | 12.56M | 13.07M | 12.77M | 14.28M |
To track all earnings releases for Champions Oncology visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.